Publications by authors named "Sue Collins"

Claim this Profile
A
A randomised phase II trial testing the acceptability and feasibility of a narrative approach to public health communication to increase community engagement with palliative care.
Anna Collins, Sue-Anne McLachlan, Mike Hill, Sue Collins, Jennifer Philip

Palliat Med· September 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Influence of predictability on control of extra-retinal components of smooth pursuit during prolonged 2D tracking.
Graham Barnes, Sue Collins

Exp Brain Res· March 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Discovery and structure-activity relationships of a series of pyroglutamic acid amide antagonists of the P2X7 receptor.
Muna H Abdi, Paul J Beswick, Andy Billinton, Laura J Chambers, Andrew Charlton, Sue D Collins

Bioorg Med Chem Lett· September 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Identification of [4-[4-(methylsulfonyl)phenyl]-6-(trifluoromethyl)-2-pyrimidinyl] amines and ethers as potent and selective cyclooxygenase-2 inhibitors.
Martin E Swarbrick, Paul J Beswick, Robert J Gleave, Richard H Green, Sharon Bingham, Sue D Collins

Bioorg Med Chem Lett· August 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Novel histamine H3 receptor antagonists GSK189254 and GSK334429 are efficacious in surgically-induced and virally-induced rat models of neuropathic pain.
Stephen J Medhurst, Sue D Collins, Andy Billinton, Sharon Bingham, Robert G Dalziel

Pain· August 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Localisation and modulation of prostanoid receptors EP1 and EP4 in the rat chronic constriction injury model of neuropathic pain.
Peter L Woodhams, Rachel E MacDonald, Sue D Collins, Iain P Chessell, Nicola C Day

Eur J Pain· August 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Investigation into the role of P2X(3)/P2X(2/3) receptors in neuropathic pain following chronic constriction injury in the rat: an electrophysiological study.
Caroline J Sharp, Alison J Reeve, Sue D Collins, Jo C Martindale, Scott G Summerfield

Br J Pharmacol· July 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
GW274150, a novel and highly selective inhibitor of the inducible isoform of nitric oxide synthase (iNOS), shows analgesic effects in rat models of inflammatory and neuropathic pain.
Jorge De Alba, Nick M Clayton, Sue D Collins, Philip Colthup, Iain Chessell

Pain· January 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Prostanoid receptor EP1 and Cox-2 in injured human nerves and a rat model of nerve injury: a time-course study.
Pascal F Durrenberger, Paul Facer, Maria A Casula, Yiangos Yiangou, Roy A Gray, Sue D Collins

BMC Neurol· January 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Social Security.
Sue Collins

Am J Nurs· July 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pharmacokinetic/pharmacodynamic modelling of the anti-hyperalgesic and anti-nociceptive effect of adenosine A1 receptor partial agonists in neuropathic pain.
Marloes P Schaddelee, Sue D Collins, Joost DeJongh, Albertus G de Boer, Adriaan P Ijzerman

Eur J Pharmacol· May 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The cyclooxygenase-2 inhibitor GW406381X [2-(4-ethoxyphenyl)-3-[4-(methylsulfonyl)phenyl]-pyrazolo[1,5-b]pyridazine] is effective in animal models of neuropathic pain and central sensitization.
Sharon Bingham, Paul J Beswick, Chas Bountra, Terry Brown, Ian B Campbell, Sue D Collins

J Pharmacol Exp Ther· March 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Identification of 2,3-diaryl-pyrazolo[1,5-b]pyridazines as potent and selective cyclooxygenase-2 inhibitors.
Paul Beswick, Sharon Bingham, Chas Bountra, Terry Brown, Kerry Browning, Sue Collins

Bioorg Med Chem Lett· November 2004

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Population pharmacokinetic-pharmacodynamic modelling of the anti-hyperalgesic effect of 5'deoxy-N6-cylopentyladenosine in the mononeuropathic rat.
Marloes P Schaddelee, Joost Dejongh, Sue D Collins, Albertus G de Boer, Adriaan P Ijzerman

Eur J Pharmacol· November 2004

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis